The development from a hormonal memory based on the hypothalamic-pituitary-adrenal (HTPA) axis is constituted by a complex set of direct influences and feedback interactions, among the components of an adrenal neuroendocrine system that during human nurturing allows hormonal communication, integrating a newborn with his family. The brain hypothalamus functions to regulate the anterior pituitary to develop hormonal (fully emotional) communication that precedes the stage of language development. A pure emotional language constitutes an unconscious, a barrier to self-cognition on the own personality dynamics. This one could be potentiated by Doppler analysis of vector neuronal emotional childhood association to the adult stage to constitute new psyche connectomes. These ones are accessible to psychoanalytic techniques that focus on the study of the psyche, and treatment by using free association to allow healing. Dehydroepiandrosterone (DHEA), an endogenous corticoid (internally produced), is the most abundant circulating steroid in humans, which is not required as vitamins, which are only available from food. DHEA is a prohormone derived from cholesterol and pregnenolone that is a precursor of mineralcorticoids (aldosterone, etc.), glucocorticoids (cortisol, etc.) and testosterone and estradiol. Usually a clinical treatment to supplement the level of testosterone or estradiol will produce the desired immediate effect, but thereafter reduce the physiological natural production, as expression of a negative feedback. DHEA might prove to have benefits in treating people diagnosed with certain conditions, such as adrenal insufficiency and lupus. Hence, these ones will respond to a physiological regulation through the attractive sexual pathways. Adolescence increases DHEA levels declining by 75-90% by the time humans hit 75-80 years old associated with a loss of function and increased risk for disease. It impacts quality of life and longevity. DHEA has become a popular anti-aging supplement. A 12 years study of old men found that an increase of 100 μg/dL of DHEA-sulfate solution injected in blood showed a 36% reduced risk of death.